| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| anifrolumab trial | 1.06 | 0.6 | 5411 | 2 | 17 |
| anifrolumab | 1.99 | 0.8 | 6719 | 57 | 11 |
| trial | 0.94 | 0.6 | 4660 | 22 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| anifrolumab approval | 0.55 | 0.5 | 2359 | 58 |
| anifrolumab tulip 2 | 0.87 | 0.7 | 7913 | 80 |
| anifrolumab australia | 0.37 | 1 | 9542 | 2 |
| anifrolumab astrazeneca | 1.37 | 0.6 | 2128 | 84 |
| anifrolumab lupus nephritis trial | 1.46 | 0.7 | 9785 | 79 |
| anifrolumab clinical trials | 1.82 | 0.1 | 4970 | 61 |
| muse trial anifrolumab | 1.53 | 0.1 | 684 | 5 |
| anifrolumab sc trial | 1.62 | 0.8 | 815 | 4 |
| anifrolumab acr | 0.22 | 0.4 | 9597 | 12 |
| anifrolumab aifa | 1.8 | 0.4 | 5006 | 51 |
| anifrolumab amm | 1.81 | 0.5 | 8986 | 93 |
| anifrolumab ansm | 0.03 | 0.4 | 9559 | 89 |
| anifrolumab aemps | 0.5 | 0.8 | 2619 | 97 |
| anifrolumab atc code | 0.21 | 0.5 | 1003 | 39 |
| anifrolumab tulip 1 | 0.91 | 0.2 | 3705 | 93 |
| anifrolumab approval history | 0.99 | 0.2 | 3446 | 6 |
| anifrolumab antagonizes which target molecule | 1.02 | 1 | 2263 | 86 |
| anifrolumab tulip | 0.02 | 0.4 | 6409 | 65 |
| anifrolumab fda approval | 0.17 | 0.8 | 4661 | 46 |
| anifrolumab summary basis of approval | 0.77 | 0.2 | 3230 | 91 |
